Gastrointestinal decontamination in the acutely poisoned patient
Timothy E Albertson1, Kelly P Owen, Mark E Sutter
1Department of Internal Medicine, School of Medicine, University of California, Davis, Sacramento, California, USA. tealbertson@ucdavis.edu.
Objective:
To define the role of gastrointestinal (GI) decontamination of the poisoned patient.
Data Sources:
A computer-based PubMed/MEDLINE search of the literature on GI decontamination in the poisoned patient with cross referencing of sources.
Study Selection And Data Extraction:
Clinical, animal and in vitro studies were reviewed for clinical relevance to GI decontamination of the poisoned patient.
Data Synthesis:
The literature suggests that previously, widely used, aggressive approaches including the use of ipecac syrup, gastric lavage, and cathartics are now rarely recommended. Whole bowel irrigation is still often recommended for slow-release drugs, metals, and patients who "pack" or "stuff" foreign bodies filled with drugs of abuse, but with little quality data to support it. Activated charcoal (AC), single or multiple doses, was also a previous mainstay of GI decontamination, but the utility of AC is now recognized to be limited and more time dependent than previously practiced. These recommendations have resulted in several treatment guidelines that are mostly based on retrospective analysis, animal studies or small case series, and rarely based on randomized clinical trials.
Conclusions:
The current literature supports limited use of GI decontamination of the poisoned patient.
Related Concept Videos
Prevention of Further Absorption of Poison
Pharmaceutical Poisoning: Treatment Strategies
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Acute Kidney Injury V: Interprofessional Care

